UC-Irvine: Immunology Researcher Secures Nearly $4 Million NIH Grant to Advance Therapeutic Vaccine to Help End Genital Herpes
June 17, 2026
June 17, 2026
IRVINE, California, June 17 -- The University of California Irvine campus issued the following news release:
* * *
Immunology researcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpes
Funding supports an innovative 'Prime/Pull/Keep' strategy to achieve long-lasting protection against HSV-2
-
University of California, Irvine immunologist Lbachir BenMohamed has been awarded a $ . . .
* * *
Immunology researcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpes
Funding supports an innovative 'Prime/Pull/Keep' strategy to achieve long-lasting protection against HSV-2
-
University of California, Irvine immunologist Lbachir BenMohamed has been awarded a $ . . .